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Purpose: Pharmacologic lysis or balloon thrombectomy are options to treat acute arterial 
thrombosis; however, little is known about their effects on functional changes in the 
arterial wall. The aim of this study was to determine function of  the endothelium and 
smooth muscle in canine arteries revascularized after acute thrombosis with balloon 
thrombectomy or lytic therapy. 
Methods: Acute thrombosis was obtained by bilateral proximal and distal ligation of 8-cm 
segments of  the femoral arteries in dogs. After 24 hours, the ties were removed and the 
arteries randomized to treatment groups: group 1, balloon thrombectomy (#4 Fogarty 
balloon catheter at 60 grams linear shear x i pass, n = 7); group 2, untreated, tie removal 
only (n = 6); group 3, regional intra-arterial urokinase infusion (4000 U/min  x 90 min, 
n = 6); group 4, regional intra-arterial carrier infusion (0.43 ml/min x 90 min, n = 6); 
group 5, unoperated normal vessels (n = 5). After treatment, he arteries were removed 
and endothelial and smooth muscle responses examined in organ chambers. Endothelial 
loss was graded with light microscopy of vessel rings from each animal by an observer 
blinded to the treatment group. Findings were confirmed with scanning electron 
microscopy. 
Results: Treatment with urokinase did not alter endothelium-dependent relaxations or 
smooth muscle contractions compared with carrier infusion or untreated alone. Balloon 
catheter thrombectomy significantly reduced endothelium-dependent relaxations com- 
pared with all other groups in response to acetylcholine, bradykinin, and thrombin 
(p < 0.001). Contractions of  smooth musde in response to potassium chloride (60 mol /L)  
and phenylephrine (1 x 10 -6 mol /L )  were also reduced (p < 0.05). Rings from balloon 
thrombectomized arteries contracted in response to calcium ionophore A23187 
(p < 0.001); these contractions were endothelium dependent and not reduced by 
indomethacin or blockade of endothelin A and B receptors. No significant differences in 
percentage of endothelial coverage between groups were assessed by light and electron 
microscopy. 
Conclusion: Thrombolysis with urokinase caused no or minimal abnormalities in endo- 
thelial and smooth muscle function. Endothelium present after balloon thrombectomy 
produces contractile factors. Although the duration and recovery of  these abnormalities in
function are unknown, these findings support preferential use of  urokinase over balloon 
thrombectomy when possible in acute arterial thrombosis or embolism. (J Vasc Surg 
1996;23:851-9.) 
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Arterial balloon thrombectomy has been well 
established as the standard fbr treating acute arterial 
embolism and thrombosis)  '2Despite the efficacy of 
this technique for removing thrombus from arteries, 
complications have been reported after its use, includ- 
ing vessel rupture, perforation, and balloon fracture 
with distal embolism.3-'~ A potential late complication 
of  this procedure is intimal hyperplasia nd possible 
progression of  atherosclerosis. 6-s Experimental and 
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clinical experiences indicate that balloon catheters 
may disrupt or denude the endothelium. 9 Most ex- 
perimental studies examining balloon thrombectomy 
have used a vigorous technique with the intent of 
completely denuding the endothelium, and their 
analysis has focused on disruption of morphologic 
features rather than functional changes. 1°,I1 Little is 
known about functional changes caused in arteries 
thrombectomized with balloon catheters with stan- 
dardized low shear. 
Thrombolytic therapy with direct-acting activa- 
tors ofplasminogen such as urokinase has become the 
first line of treatment for acute thrombosis. The 
efficacy of intra-arterial thrombolytic therapy in 
achieving lysis of thrombus and initial patency of 
recently thrombosed arteries and grafts has been well 
established) 2q7 Data on functional changes after 
urokinase treatment are not available. 
The vascular endothelium plays an important role 
in regulation of arterial tone, in differentiation and 
growth of the underlying smooth muscle and in 
thrombogenicity through release of substances such 
as nitric oxide ~s and endothelins) 9,2° How lytic 
therapy affects the ability ofendothelium toproduce 
and release vasoactive substances that are so impor- 
tant to the normal function of an artery is unclear. 
Therefore this study was designed to determine 
effects of thrombolytic therapy and balloon throm- 
bectomy on endothelial nd smooth muscle function 
in an experimental model of acute arterial thrombosis. 
MATERIAL AND METHODS 
Animal model. Male mongrel dogs (weight 24 to 
26 kg) were anesthetized with intravenous sodium 
pentobarbital (30 mg/kg). Animal care was in com- 
pliance with the "Principles of Laboratory Animal 
Care" formulated by the National Society for Medical 
Research and the "Guide for the Care and Use of 
Laboratory Animals" prepared by the National Acad- 
emy of Sciences and published by the National 
Institutes of Health (NIH Publication No. 86-23, 
revised 1985). Hydration was maintained with intra- 
venous sodium chloride (0.9%) solution at a rate of 
7 ml/kg/hr.  
By using an aseptic surgical technique , the femoral 
arteries were exposed. The advenritia nd vasa va- 
sorum were disturbed only in the areas where ties 
were to be placed. Both femoral arteries were ligated 
with a 2-0 silk suture proximally below the inguinal 
ligament and 8 cm distally above the femoral bifurca- 
tion. Side branches of the femoral arteries were 
double ligated. Lack of blood flow was confirmed 
with an ultrasonic flow probe (Transonics Systems 
Inc., Ithaca, N.Y.). The groin wounds were closed in 
layers. Twenty-four hours later the femoral vessels 
were exposed again, ties were removed, and each 
artery was assigned to one of four treatment groups. 
The iliac arteries were cannulated with an 18-gauge 
Teflon catheter for infusions and arteriograms. An- 
giograms were performed in all limbs with 50% 
diatrizoate meglumine after treatment but before 
harvesting the vessels. The animals were sacrificed 
after the arteries were harvested. 
Thirty arteries were randomized before the start 
of the study into four groups. Group 1 underwent 
balloon thrombectomy (n = 7). A #4 Fogarty bal- 
loon catheter (Baxter Healthcare, Santa Ana, Calif.) 
connected to a force transducer (Model FT03, Grass 
Instrument Co., Quincy, Mass.) was inserted through 
an arteriotomy atthe level of the femoral bifurcation. 
The balloon was positioned in the iliac artery and 
inflated with fluid while withdrawing the catheter 
under arterial pressure. While withdrawing the bal- 
loon through the femoral artery, inflation was con- 
trolled to keep the linear shear stress as close to 60 gm 
as possible (Fig. 1). The balloon was removed after 
one withdrawal in all limbs. Group 2 was untreated; 
the ties were removed from the ligated artery after 24 
hours, and the vessel was harvested (n = 6). Group 3 
received uroldnase (n = 6). A Harvard pump (Har- 
vard Apparatus, Millis, Mass.) was used for continu- 
ous intra-arterial infusion ofuroldnase. Two hundred 
fifty thousand units of urokinase as lyophilized pow- 
der were reconstituted with 5 ml of sterile water and 
brought o a volume of 27 ml with sterile saline for a 
final concentration f 9260 U/ml.  The lyric agent was 
then infused at 0.43 ml/min (4000 U/min)  for 90 
minutes. Group 4 received the carrier solution (0.5% 
mannitol, 5% human albumin, and 1% sodium chlo- 
ride in sterile water), which was intra-ar terially infused 
at 0.43 ml/min for 90 minutes (n = 6). Group 5 
consisted of unoperated normal vessels (n = 5). All 
arteries were removed and cut into sections for 
histologic examination and organ chamber experi- 
ments. 
In vitro studies. Femoral arteries were removed 
from each animal and sectioned into four rings (5 mm 
in length). The rings were immersed in a chilled, 
modified Krebs-Ringer bicarbonate solution (control 
solution) of the following millimolar concentration: 
sodium chloride 118.3, potassium chloride 4.7, cal- 
cium dichloride 2.5, magnesium sulfate 1.2, potas- 
sium phosphate 1.22, sodium bicarbonate 25.0, glu- 
cose 11.1, edetate calcium disodium 0.026. The 
endothelium was removed from two of the four rings 
by gentle intraluminal rubbing with a fine forceps tip. 
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Rings were suspended between afixed point and a 
force transducer (Gould UC2, Cleveland, Ohio) to 
measure isometric force. The rings were placed in 
organ baths filled with 25 ml control solution at 
37 ° C and gassed with 95% oxygen and 5% carbon 
dioxide. The rings were allowed to equilibrate for 30 
minutes. Rings were then gradually stretched in 
stepwise fashion to the optimal point of their length- 
tension relation as determined by tension developed 
to potassium chloride (20 retool/L). Contraction to 
potassium chloride (60 mmol /L)  was measured. One 
group of rings with and without endothelium from 
each treatment group was incubated with the argi- 
nine analog Na-monomethyl-L-arginine (L-NMMdk) 
(10 -4 tool/L)  for 30 minutes before the first concen- 
tration response curve. L-NMMA was readded to 
these chambers before each concentration response 
curves. The rings were then contracted with prosta- 
g land in  F2a (2 X 10 -5 tool/L).  Cumulative concen- 
tration-response curves to the following agents were 
then recorded after submaximal contraction with 
phenylephrine (1 x i0 -6 mol/L):  acetylcholine (10 -9 
tO l0  -6 mol/L) ,  bradykinin (10  -9 to 10 -6 tool/L),  
and thrombin ( i0 -2 to 1.0 U/ml) .  Contractions were 
measured from baseline tension in response to endo- 
thelin-1 (10 -n to 10 -7 tool/L).  Relaxations to nitric 
oxide (3 x 10 -s to 10 -s mol /L)  in rings without 
endothelium and calcium ionophore A2 3187 ( 10 -9 to 
I0 -6 mol /L)  in rings with endothelium were mea- 
sured from the maximal contraction obtained with 
endothelin-1. In parallel experiments, rings from 
balloon thrombectomized arteries were incubated 
with indomethacin (1 x 10 -s mol /L)  and SB-209670 
(I x l0 -s mol /L)  (nonselective antagonist of endo- 
thelin A and B receptors) before the calcium iono- 
phore A23187 dose response curves (n = 2). 
Drugs. The following drugs were used: acetyl- 
choline, bradyldnin, calcium ionophore A23187, en- 
dothelin-1, L-NMMA, thrombin, indomethacin, and 
SB209670. Drugs were prepared aily with distilled 
water and kept refrigerated. The calcium ionophore 
was dissolved in dimethyl sulfoxide and diluted in 
distilled water (final bath concentration of dimethyl 
sulfoxide was 8.2 x 10 -3 mol/L) .  Nitric oxide was 
prepared according to the method as previously 
described. 21All concentrations refer to final molar 
(tool/L) concentrations of drugs in the organ bath or 
superfusion solution. 
Calculations and statistical analysis. All data are 
expressed as mean + SEM. The n value represents he 
number of arteries. Relaxations are expressed as a 
percentage of the contraction to phenylephrine or 
endothelin- 1.Contractions are expressed as increases 
J 
Fig. 1. Diagram demonstrating method of controlled bal- 
loon catheter thrombectomy. Linear shear is measured with 
force transducer. Linear shear is kept close to 60 grams by 
controlling balloon inflation during catheter withdrawal. 
in grams of tension or percentage of the contraction 
to potassium chloridc (60 mmol/L) .  Differences in 
contractions among groups were detcrmincd by the 
use of a one-way analysis of variance of the area under 
the curves. The Student's-Newman-Keuls po t hoc 
analysis was used to identify differences between 
groups. Statistical significance was accepted when 
p < 0.05. 
Histologic analysis. Endothelial damage of rings 
fixed immediately after the intervention was assessed 
by light microscopy of" sections (stained with hema- 
toxylin and eosin) and electron microscopy. Damage 
was scored by an observer blinded to the treatment 
groups. Rings were divided into quadrants and per- 
centage of endothelial denudation assessed. This 
percentage was converted to a score for each ring (0% 
to 10% = l, 11% to 25% = 2, 26% to 50% = 3, 51% to 
75% = 4, and 76% to 100% = 5). The results were 
expressed as a mean +_ SEM. Analysis of variance was 
used to identify differences between treatment 
groups. 
RESULTS 
All femoral arteries were filled with soft thrombus 
24 hours after ligation. Removal of the proximal and 
distal ligatures resulted in most but not all of the 
thrombus being swept away. Balloon thrombectomy 
resulted in linear shear measurements of 60 + 10 mm 
Hg. All vessels were patent after treatment as demon- 
strated by arteriography. 
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Fig. 2. Contraction-response curves to phenylephrine (PE) (1 x 10 -6) and potassium chloride 
(KCI) (60 mmol/L) in femoral rterial rings with intact endothelium. Data are mean + SEM of 
change in tension (grams). Responses of rings without endothelium (not shown) were not 
different from those with endothelium. Contraction of balloon-thrombectomized rings was 
significantly decreased (p < 0.05) compared with other groups. 
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Fig. 3, Contraction-response curves to acetylcholine in femoral arterial rings with intact 
endothelium. Data are mean + SEM of percent change in tension from contraction to 
phenylephrine (1 x 10 -6 tool/L). Relaxation ofballoon-thrombectomized r ngs was significantly 
decreased (p < 0.001) compared with groups 2, 3, and 4. 
Organ chamber studies 
All rings contracted to potassium chloride (60 
mmol /L)  and phenylephrine (1 x 10 -6 tool/L).  
There were no differences in contractions between 
urokinase and carrier-infused arteries. Contraction of 
rings from balloon thrombectomized arteries was 
significantly less in response to potassium chloride 
and phcnylephrinc compared with all other groups 
(p < 0.05; Fig. 2). 
Acetylcholine. In rings with endothelium, acetyl- 
choline caused concentration-dependent r laxations 
in uroldnase, carrier-infused, and untreated arterial 
rings without significant differences among these 
groups. Relaxations offings from balloon thrombec- 
tomized arteries were significantly ess than groups 2, 
3, and 4 (p < 0.001; Fig. 3). In this group, 5 of 7 rings 
relaxed to acetylcholine while 2 of 7 had no response. 
Rings from all groups with endothelium echanically 
removed contracted without significant differences. 
Bradykinin. In rings with endothelium, bradvld- 
nin caused concentration-dependent r laxations in 
urokinase, carrier-infused, and untreated arterial rings 
without significant differences among these groups. 
Rings from balloon-throlnbectonfizcd arteries con- 
tracted significantly in rcsponsc to bradykinin 
(p < 0.001 fbr group 1 vs all othcr groups; Fig. 4) 
with only 1 of 7 rings relaxing below initial tension 
developed to phcnylcphrinc. Rings fi'om all groups 
with endothelium echanicalh' rcmovcd contracted 
without significant diflkrcnccs among groups. 
Thrombin.  In rings with cndothcliunL thrombin 
caused concentration-dependent relaxations in uroki- 
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Fig. 4. Contraction-response curves to bradykinin in femoral arterial rings with intact endot- 
helium. Data are mean + SEM of percent change in tension from contraction to phenylephrine 
(1 × 10 6 mol/L). Relaxation of balloon thrombectomized rings was significantly decreased 
(p < 0.001 for group 1 vs all other groups) compared with all other groups. 
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Fig. 5. Contraction-response curves to thrombin in femoral arterial rings with intact endot- 
helium. Data are mean + SEM of percent change in tension from contraction to phenylephrine 
( 1 × 10 -6 mol/L). Relaxation ofballoon-thrombectomized ringswas significantly decreased (p < 
0.001) compared with all other groups. 
nase, carrier-infused, and untreated arterial rings. 
There were no significant differences among these 
groups. Rings from balloon-thrombectomized arter- 
ies contracted significantly compared with all other 
groups (p < 0.001; Fig. 5). Rings from all groups with 
endothelium echanically removed contracted with- 
out significant differences among groups. 
Endothel in-1.  Concentration-dependent i -
creases in tension were observed to endothelin- 1. The 
contractions were not significantly different in rings 
with or without endothelium. 
Calcium ionophore A23187.  In rings with en- 
dothelium contracted with endothelin-1, calcium 
ionophore A23187 caused concentration-dependent 
relaxations in rings from uroldnase, carrier-infused, 
and untreated arteries. There were no signifi- 
cant differences among these groups. Rings from 
balloon-thrombectomized arteries contracted signifi- 
cantly in response to calcium ionophore A23187 
compared with all other groups (p < 0.001; Fig. 6). 
The contractions to calcium ionophore A23187 in 
the balloon thrombectomy group seen at higher 
concentrations was endothelium dependent and not 
abolished by incubation with indomethacin or 
SB209670 as demonstrated in parallel experiments 
(n = 2). L -NMMA did not alter the contractions seen 
in the balloon thrombectomy group. 
Nitr ic oxide. Rings from all groups relaxed in a 
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Fig. 6. Contraction-response curves to calcium ionophore A23187 in femoral arterial rings 
with intact endothelium. Data are mean _+ SEM of percent change in tension from contraction 
to endothelin-1 (1 x 10 7 tool/L). Balloon-thrombectomized rings paradoxically contracted 
(p < 0.001) compared with all other groups. 
Table I. Degree of endothelial loss in 
treated arteries 
Treatment group n Mean +_ SEM 
Urokinase infusion 6 1.5 + 0.34 
Carrier infusion 4 2.25 + 0.75 
Balloon thrombectomy 7 3.0 + 0.57 
Untreated 5 1.8 + 0.8 
Percentage of endothelial loss for rings from each vessel was 
determined byan observer blinded to treatment groups converted 
to numeric value according to scale: 0% to 10% = 1, 11% to 
25% = 2, 26% to 50% = 3, 51% to 75% = 4, 76% to 100% denuda- 
tion = 5. Differences were not significant (p > 0.05). 
concentration-dependent fashion to  nitric oxide. Re- 
laxations were not significantly different among 
groups. 
Histologie study 
Light microscopy of sections prepared from arter- 
ies immediately after intervention revealed small areas 
of denudation in all groups. The differences in 
amount of lumen covered with endothelium among 
groups were not significant (p > 0.05; Table I). There 
was no correlation in degree of endothelial denuda- 
tion and relaxation or contractile responses. These 
findings were confirmed with scanning electron mi- 
croscopy of representative arteries from each group 
(urokinase infusion, n = 4; carrier infusion, n = 3; 
balloon thrombectomy, n = 4; untreated, n = 3). 
D ISCUSSION 
In this study, organ chamber experiments and 
histologic examination demonstrated that regional 
infusions of urokinase did not inhibit endothelium- 
dependent relaxations or smooth muscle contractions 
or visibly alter endothelial architecture. However, 
gentle balloon catheter thrombectomy significantly 
inhibited endothelium-dependent relaxations and 
smooth muscle contractions without significantly 
altering endothelial histologic features. The endothe- 
lium remaining after balloon catheter thrombectomy 
produced contractile factors. Thrombosis alone did 
not significantly alter endothelial or smooth muscle 
function. 
Thrombolytic agents arc used in patients because 
of their ability to alter the fibrinolytic cascade. The 
biology of these agents is quite diverse. The activation 
of plasminogen to the protease, plasmin is a mecha- 
nism for producing cxtracellular proteolysis 22 and 
may have roles in a variety of biologic processes, 
including fibrinolysis, placental implantation, migra- 
tion of normal and malignant cells, and tissue remod- 
eling. 23'24 Endothelial cells express receptors for plas- 
minogen and uroldnase-like plasminogen activator. 
These receptors may have a role in cell-cell interac- 
tion, permeability, and migration. 25-27 Given the 
broad spectrum of activity of plasmin and receptors 
for plasminogen activators uch as urokinase, it was 
not clear if their use would result in immediate ffects 
on the vessel wall. Results of this study demonstrate 
that intra-arterial infusions of urokinase in doses 
similar to those used in patients resulted in minimal or 
no alterations in endothelial-dependent relaxation or 
smooth muscle contraction compared with infusions 
of carrier solution in stark contrast to balloon throm- 
bectomy. 
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Studies have used balloon catheters to completely 
denude the endothelium as a model for vascular in- 
jury, l°,H whereas others have controlled the amount 
of force applied to the vessel wall to recreate as nearly 
as possible anormal operative thrombectomy. 9 Denu- 
dation of the cndothelium has been associated with 
accelerated atherosclcrosis, 28 and even mild injury 
may bc associated with intimal hypcrplasia. 4,6,29 Most 
studies with balloon catheter thrombcctomy have de- 
scribed the degree of vessel injury in histologic terms. 
Very little is known about the functional effect of  a 
"surgical" balloon thrombectomy in an occluded ar- 
tery. It appears that endothelial injury depends on 
balloon inflation and the number of catheter with- 
drawals. "Gentle" controlled balloon thrombecto- 
mics were performed by carefully regulating dynamic 
shear forces during one catheter withdrawal as de- 
scribed by Jorgensen and Dobrin. 9 A controlled bal- 
loon thrombectomy caused insignificant denudation 
of endothelium compared with other groups; how- 
ever, vessel rings from this group demonstrated pro- 
foundly decreased ability to generate dose-dependent 
cndothelium-dcpendent relaxations and smooth 
muscle contractions. The arteries relaxed only slightly 
to the highest concentrations of acetylcholinc om- 
pared with all other groups, whereas there were no 
appreciable r laxations to any other agent hat gener- 
ally elicits an endothelium-depcndent relaxation 
(bradykinin and thrombin), The histologic presence 
of endothclium does not necessarily translate to nor- 
mal functioning endothelium. It was apparent hat 
the endothelium remaining within the vessel sus- 
tained a physiologic insult by the balloon. Nitric oxide 
causes a endothelium-independent smooth muscle 
relaxation. 21 M1 vessel rings relaxed in a similar fashion 
when exposed to nitric oxide. This finding proves that 
the smooth muscle in balloon-thrombcctomized ar- 
teries is able to relax in response to endothelium- 
derived relaxing factors; however, the endothelium 
did not appear to release them in the expected fashion. 
The internal elastic lamina and smooth muscle ap- 
peared intact in the balloon thrombectomy group; 
however, smooth muscle contractions were signifi- 
cantly decreased. The ability of the endothelium to 
influence the underlying smooth muscle is respon- 
sible for the ability of the vessel to alter its tone and to 
undergo vessel wall remodeling. 3°Surprisingly, cal- 
cium ionophore A23187 elicited a significant 
endothelium-dependent contraction in the balloon- 
thrombectomized arteries. The mechanism of this 
contraction is not yet clearly understood; however, it 
has been seen in other tissues and may be caused by 
superoxide anions and alterations in cyclooxygenase 
pathways. 31-33 Production of endothelial contractile 
factors and diminished smooth muscle function may 
ultimately contribute to the eventual pathologic se- 
quela of vessel stcnosis or occlusion. 
Thrombolysis with uroldnase has gained wide- 
spread use among vascular surgeons and appears to be 
a safe alternative to balloon catheter thrombectomy. 16 
In cxperiments, urokinase prescrved endothelial and 
smooth muscle function in an experimental model of 
artcrial thrombosis of 24-hour duration. However, 
gentle balloon catheter thrombectomy similar to that 
in use by most vascular surgeons seriously altered 
arterial physiologic features and the vessels' ability to 
normally adapt to a changing milieu. Although the 
significance, duration, and recovery of these abnor- 
malities in function are unlcnown, these findings 
support preferential use of uroldnase over balloon 
thrombcctomy when possible in acute thrombosis or 
embolism. 
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D ISCUSSION 
Dr. Dolores F. Cikr it  (Indianapolis, Ind.). Even 
though you controlled for linear sheer stress, did you try 
using a smaller Fogarty catheter to assess its effect on 
smooth muscle cells? Because balloon thrombectomy 
caused the vessels to lose contractility, should we be using a 
calcium-channel b ocker at the completion of  our arterial 
thrombectomies? In your study, the clots were present for 
only 24 hours, and the majority of  this was swept away as 
soon as blood flow was re-established to the vessel. This 
does not happen in thc clinical setting. Uroldnase will sit in 
the occluded vessel for a period of time before the clot is 
lysed. Did you do any studies with the distal tie on to assess 
the long-term effect ofuroldnase on the endothelial lining? 
It was surprising that endothelial denudation was similar in 
all groups. Did you use a factor VII I  stain to quantify 
endothelium coverage? Did you do any studies with pres- 
sure perfusion to maintain endothelial contact? 
Dr. David Whitley. In response to your first question, 
no, we did not use a smaller catheter. We had a limited 
amount of  time and animals to do this, and we decided on 
one size. 
As far as your second question regarding use of a 
calcium-channel b ocker, I think this tells us that if we see 
spasm in an artery after a balloon thrombectomy, we would 
need to use something that is going to act directly on the 
smooth muscle if we are going to try to get rid of the spasm. 
Agents that normally would cause relaxation with an intact 
endothelium ay actually end up causing a contraction--  
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such as acetylcholine, bradykinin, and thrombin, all of 
which actually cause significant contraction. We need to 
keep that in mind. 
As far as your question about ie removal, it is true that 
the clot formed up to 24 hours was a soft clot, and some of 
that actually did sweep away when the ties were taken off. 
We might have seen higher concentrations of urokinase 
within that artery bad we left the distal tie on for a period 
during the infusion. However, we did do a series of 
experiments in whicb we added purified urokinase directly 
to the organ chambers and actually saw no effect on 
endothelial function. 
Lastly, we did not stain fbr factor VIII. Since this was an 
acute stud)', we had good histology and scanning electro- 
microscopy, so anything we saw lining the vessel was going 
to be endothelium. We did not do any perfusion studies. 
Perfusing these vessels would have been nice; however, ifwe 
had done that, we would not have been able to carry out the 
functional studies. 
Dr. John D. Corson (Iowa City, Iowa). The pharma- 
ceutical companies, our interventional colleagues, and oth- 
ers are exhorting us to try to lyse things that have been 
thrombosed for significant periods of time. What do we 
really know about the effect of the thrombus itself on 
endothelial function vis-~t-vis the time the thrombus is 
there? Have you looked at that as a factor in the longer term? 
Dr. Whitley. Not in the longer term. I actually have 
looked at the literature, and there is very little known about 
how it affects the function of the endothelium. In the 
beginning we were not quite sure if our endothelium was 
going to be affected by the clot sitting within the artery for 
a period of time. However, as you can see from the controls, 
the endothelium, atleast by our study, seems to fare very 
well and had normal responses to all the agents that we 
looked at. I cannot give you any information on the 
long-term effect. 
Dr. Thomas W. Wakefield (Ann Arbor, Mich.). Be- 
cause you had loss of endothelial cells in the balloon group, 
are you sure that you just did not have enough endothelial 
cells remaining to respond appropriately rather than con- 
cluding that these endothelial cells did not work because of 
the balloon injury? 
Dr. Whitley. We had endothelium present in all the 
vessel rings that we examined. We studied adjacent vessel 
rings before hanging them in the organ chamber. We also 
stained and looked at the vessel rings after they came out of 
the chamber. M1 vessel rings had endothelium present. 
There was obviously more endothelium denuded in the 
balloon thrombectomy group, and we tried to correlate that 
with the function. There was not a positive correlation 
between the degree of denudation and the function. Usu- 
ally in these vessel rings if you have any endothelium 
present, you will have almost near-normal endothelium- 
dependent relaxation. 
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